These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4196420)

  • 1. [Effect of an inhibitor of the immunogenic response on the development of tolerance to delta 9 tetrahydrocannabinol].
    Nahas G; Schwartz I; Palacek J; Zagury D
    C R Acad Hebd Seances Acad Sci D; 1973 Jan; 276(4):667-8. PubMed ID: 4196420
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance of delta-9-tetrahydrocannabinol in the spontaneously hypertensive rat.
    Nahas GG; Schwartz IW; Adamec J; Manger WM
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):58-60. PubMed ID: 4683264
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins and cannabis--XI. Inhibition of delta 1-tetrahydrocannabinol-induced hypotension by aspirin.
    Burstein S; Ozman K; Burstein E; Palermo N; Smith E
    Biochem Pharmacol; 1982 Feb; 31(4):591-2. PubMed ID: 6279113
    [No Abstract]   [Full Text] [Related]  

  • 4. Physostigmine attenuation of delta 9-tetrahydrocannabinol induced hyperthermia in rats.
    Johansson JO; Järbe TU; Henriksson BG
    Experientia; 1974 Jul; 30(7):779-80. PubMed ID: 4847670
    [No Abstract]   [Full Text] [Related]  

  • 5. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man.
    Karniol IG; Shirakawa I; Kasinski N; Pfeferman A; Carlini EA
    Eur J Pharmacol; 1974 Sep; 28(1):172-7. PubMed ID: 4609777
    [No Abstract]   [Full Text] [Related]  

  • 6. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the possible immunogenicity of delta 9-tetrahydrocannabinol (THC) in rodents.
    Nahas GG; Zagury D; Schwartz IW; Nagel MD
    Nature; 1973 Jun; 243(5407):407-8. PubMed ID: 4743633
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tolerance to delta 9-tetrahydrocannabinol in the hypertensive rat].
    Nahas G; Schwartz I; Palacek J; Zagury D
    C R Acad Hebd Seances Acad Sci D; 1972 Oct; 275(17):1931-2. PubMed ID: 4196760
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism by chlornaltrexamine of some effects of delta 9-tetrahydrocannabinol in rats.
    Tulunay FC; Ayhan IH; Portoghese PS; Takemori AE
    Eur J Pharmacol; 1981 Mar; 70(2):219-24. PubMed ID: 6266844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The delay of the behavioral effects of 9 -tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A).
    Peterson DW; Cohen GM; Sparber SB
    Life Sci I; 1971 Dec; 10(24):1381-6. PubMed ID: 5146321
    [No Abstract]   [Full Text] [Related]  

  • 11. Tolerance to the hypothermic and aggression-attenuating effect of delta 8 - and delta 9 - tetrahydrocannabinol in mice.
    Ten Ham M; De Jong Y
    Eur J Pharmacol; 1974 Sep; 28(1):144-8. PubMed ID: 4473345
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of repeated doses of l-delta 8-trans-tetrahydrocannabinol on schedule-controlled temporally-spaced responding of rats.
    Frankenheim JM
    Psychopharmacologia; 1974; 38(2):125-44. PubMed ID: 4460069
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol.
    Karniol IG; Carlini EA
    Psychopharmacologia; 1973 Oct; 33(1):53-70. PubMed ID: 4358666
    [No Abstract]   [Full Text] [Related]  

  • 14. 9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat.
    Newman LM; Lutz MP; Gould MH; Domino EF
    Science; 1972 Mar; 175(4025):1022-3. PubMed ID: 5061865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rabbit behavioral model of marijuana psychoactivity in humans.
    Consroe P; Fish BS
    Med Hypotheses; 1981 Aug; 7(8):1079-90. PubMed ID: 6270517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic delta-9-tetrahydrocannabinol. Transient and lasting effects on avoidance behavior.
    Manning RJ
    Pharmacol Biochem Behav; 1976 Jan; 4(1):17-21. PubMed ID: 1265092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic Delta(9)-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze.
    Nava F; Carta G; Colombo G; Gessa GL
    Neuropharmacology; 2001 Sep; 41(3):392-9. PubMed ID: 11522331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of some components of Cannabis sativa on the regenerating planarian worm Dugesia tigrina.
    Lenicque PM; Paris MR; Poulot M
    Experientia; 1972 Nov; 28(11):1399-400. PubMed ID: 4638934
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular and respiratory effects of cannabis in cat and rat.
    Graham JD; Li DM
    Br J Pharmacol; 1973 Sep; 49(1):1-10. PubMed ID: 4787563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.